Trials / Completed
CompletedNCT00269061
Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin
An Exploratory MRI Study in Type 2 Diabetic Subjects: A Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Measurement of Fluid Volumes by MRI in the Lower Extremities of Subjects Receiving Pioglitazone
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (planned)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will use Magnetic Resonance Imaging (MRI) techniques to evaluate changes in fluid volume in the lower legs of diabetic patients who add either pioglitazone or placebo to their current diabetic regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pioglitazone |
Timeline
- Start date
- 2006-01-01
- First posted
- 2005-12-23
- Last updated
- 2008-10-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00269061. Inclusion in this directory is not an endorsement.